Participants to the study will be assigned to 7 cohorts according to the stage of disease and planned antitumor treatment at time of study entry.
In all patients, 12 ml of blood sample will be collected in EDTA tube for analysis of biological biomarkers in different time points.
Age ≥ 18 years
Histological diagnosis of prostate adenocarcinoma at different stages of disease (see Section 6.2) for which a treatment is indicated
Written Informed Consent
Active infection requiring treatment
Decrease of general condition
Concomitant severe comorbities
Difficult socioeconomic conditions making regular follow up unfeasible.
7
Treatment groupsSee each treatment group below.
Oncology Institute of Southern Switzerland
Lead sponsor
Clinical Trial Unit Ente Ospedaliero Cantonale
Collaborator